Related Experiment Video
Updated: Jul 29, 2026

Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice
Published on: February 3, 2023
Prognostic value of brown adipocyte-related genes in colorectal cancer: a multi-omics and Mendelian randomization
HuaSheng He1, Yuanbiao Wang2, Huilan Kuang1
1Department of Medical Oncology, Ganzhou Cancer Hospital, Ganzhou, 341000, Jiangxi, China.
Background:
Brown adipocytes are vital in cancer's emergence and progression. However, such significance of brown adipocytes-related genes (BARGs) in colorectal cancer (CRC) still awaits exploration. The potential prognostic mechanisms of BARGs in CRC were aimed to be explored in this study.
Methods:
Datasets related to CRC were obtained from public databases. Candidate genes were pinpointed by synthesizing the findings from analysis of differential expression and Weighted Gene Co-expression Network Analysis (WGCNA). Utilizing Mendelian randomization (MR), sensitivity analysis, and the Steiger test, the feature genes causally linked to CRC were precisely pinpointed. Then, prognostic genes were identified using univariate Cox analysis and machine learning algorithms, and a prognostic model was developed and validated. In addition, the construction and evaluation of nomograms, analysis of the immune microenvironment, drug sensitivity, and functional enrichment were also carried out.
Results:
Altogether, 168 characteristic genes were pinpointed through MR analysis. ADD2, PDE1B, LZTS1, and PCSK5 were identified as prognostic genes. The area under the curve (AUC) values of receiver operating characteristic (ROC) for both the prognostic model and the nomogram were greater than 0.6, indicating high accuracy. Additionally, positive correlations were found among the differentially expressed immune cells, and PDE1B exhibited the most significant positive correlation with regulatory T cells. A variety of chemotherapeutic drugs were more significantly effective in treating CRC patients in low-risk group (LRG). Gene Set Enrichment Analysis (GSEA) demonstrated that the pathways linked to cell microenvironment remodeling and migration regulation were significantly enriched between high-risk group (HRG) and LRG.
Conclusion:
ADD2, PDE1B, LZTS1, and PCSK5 were identified as prognostic genes. A prognostic model related to BARGs in CRC was established, offering fresh perspectives on the prognostic treatment of CRC.
More Related Videos
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

